V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019516 | 270008839 | 1.95 | 76 | Curative (C) | 2014-09-08 | 2015-10-02 | BEAM | 02 | N | 270014542 | BEAM |
| 270019517 | 270008846 | 1.69 | 58 | Adjuvant (A) | 2015-11-14 | 2015-11-15 | OEPA | null | Y | 270014553 | OEPA |
| 270019518 | 270008850 | 1.88 | 92 | null | 2016-11-21 | 2016-12-21 | Rituximab | N | N | 270014558 | RITUXIMAB |
| 270019519 | 270008858 | 0 | 64 | Curative (C) | 2017-03-24 | 2018-03-25 | BEAM | N | N | 270014564 | BEAM |
| 270019520 | 270008876 | 1.74 | 122.5 | Curative (C) | 2018-02-25 | 2018-02-27 | ESHAP | 2 | N | 270014596 | ESHAP |
| 270019521 | 270014183 | 1.78 | 62.4 | Adjuvant (A) | 2015-06-04 | 2015-06-04 | OEPA | null | null | 270014625 | OEPA |
| 270019522 | 270008898 | 1.72 | 17 | Neo-adjuvant (N) | null | 2018-04-20 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270014627 | OEPA |
| 270019523 | 270018275 | 2 | 88.9 | Palliative (P) | 2016-11-15 | 2018-03-01 | Cetuximab + FOLFIRI cycle1 | 02 | null | 270014646 | CETUXIMAB + IRINOTECAN + MDG |
| 270019524 | 270016780 | 1.74 | null | null | 2016-02-03 | 2016-02-10 | CISPLATIN + RT | 02 | N | 270014658 | CISPLATIN + RT |
| 270019525 | 270008913 | 1.77 | 64 | Curative (C) | 2015-12-12 | 2016-09-02 | Mini BEAM | 2 | N | 270014660 | BEAM |
| 270019526 | 270014199 | 1.64 | null | Palliative (P) | 2016-11-15 | 2016-11-15 | OEPA | N | N | 270014681 | OEPA |
| 270019528 | 270008956 | 1.72 | 73.2 | Disease modification (D) | 2015-03-29 | 2015-04-05 | LEAM | 02 | N | 270014758 | LEAM |
| 270019529 | 270019912 | 1.66 | 86.1 | Curative (C) | 2017-01-22 | 2017-02-03 | ESHAP | N | N | 270014763 | ESHAP |
| 270019530 | 270008969 | null | 52.95 | Curative (C) | 2013-12-15 | 2015-06-17 | Rituximab | 2 | N | 270014784 | RITUXIMAB |
| 270019531 | 270008975 | 1.6 | 70.6 | Curative (C) | 2014-06-27 | 2014-07-18 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014790 | CISPLATIN + RT |
| 270019532 | 270008980 | 1.63 | null | Adjuvant (A) | null | 2016-06-09 | OEPA | 2 | N | 270014792 | OEPA |
| 270019533 | 270008992 | null | 66.8 | Palliative (P) | 2017-08-27 | 2017-09-24 | Cetuximab + FOLFIRI cycle1 | 01 | N | 270014823 | CETUXIMAB + IRINOTECAN + MDG |
| 270019534 | 270008996 | 1.8 | 90 | Curative (C) | null | 2017-12-26 | Rituximab | null | N | 270014831 | RITUXIMAB |
| 270019535 | 270018291 | 1.88 | 90.8 | Curative (C) | 2015-02-06 | 2015-02-07 | LEAM | 2 | N | 270014855 | LEAM |
| 270019536 | 270009026 | 1.57 | 57.8 | Palliative (P) | 2017-03-18 | 2017-03-31 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014886 | CETUXIMAB + IRINOTECAN + MDG |
| 270019537 | 270009038 | 1.76 | 48.5 | Curative (C) | 2012-02-20 | 2016-06-05 | LEAM | 2 | N | 270014900 | LEAM |
| 270019538 | 270009040 | null | 51 | Palliative (P) | 2013-08-01 | 2013-08-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | 270014907 | CETUXIMAB + IRINOTECAN + MDG |
| 270019539 | 270016809 | null | 63 | Curative (C) | null | 2016-06-28 | Mini BEAM | N | N | 270014941 | BEAM |
| 270019540 | 270014242 | 1.57 | 57.1 | Curative (C) | 2018-11-25 | 2018-12-16 | ESHAP | N | N | 270014959 | ESHAP |
| 270019541 | 270009067 | 1.73 | 68 | Curative (C) | 2018-07-09 | 2018-08-15 | LEAM | N | N | 270014962 | LEAM |
| 270019542 | 270009074 | 1.8 | 62.3 | Curative (C) | 2014-10-25 | 2014-10-25 | LEAM | N | N | 270014974 | LEAM |
| 270019543 | 270009080 | 1.69 | 98.999 | Curative (C) | 2017-12-04 | 2017-12-05 | Cisplatin + Radiotherapy | 02 | N | 270014979 | CISPLATIN + RT |
| 270019544 | 270009086 | 1.69 | 77.9 | Palliative (P) | 2018-09-23 | 2018-09-23 | Cetuximab + FOLFIRI cycle 2 onwards | null | null | 270014985 | CETUXIMAB + IRINOTECAN + MDG |
| 270019545 | 270020066 | 1.71 | 71.4 | Palliative (P) | 2017-11-28 | 2017-12-24 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270014996 | CETUXIMAB + IRINOTECAN + MDG |
| 270019546 | 270009092 | 1.54 | 82.4 | Palliative (P) | null | 2018-04-04 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014999 | CETUXIMAB + IRINOTECAN + MDG |
| 270019547 | 270009098 | 1.77 | 58.9 | Curative (C) | 2017-06-29 | 2017-07-04 | OEPA | 02 | null | 270015004 | OEPA |
| 270019548 | 270014260 | 1.7 | 97.5 | null | 2016-12-22 | 2016-12-26 | HD EuroNet-PHL-C1 OEPA | N | null | 270015011 | OEPA |
| 270019549 | 270019157 | 1.54 | 65 | Curative (C) | 2014-10-15 | 2014-10-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | 270015043 | CETUXIMAB + IRINOTECAN + MDG |
| 270019550 | 270014267 | 1.74 | 75.7 | Curative (C) | null | 2018-02-11 | Cisplatin + Radiotherapy | null | Y | 270015048 | CISPLATIN + RT |
| 270019551 | 270019159 | 1.29 | 57.6 | Curative (C) | 2014-08-24 | 2014-08-28 | OEPA | N | Y | 270015083 | OEPA |
| 270019552 | 270020241 | 1.76 | null | Curative (C) | 2016-02-13 | 2016-02-16 | OEPA | 2 | N | 270015099 | OEPA |
| 270019553 | 270009138 | 0 | 79.4 | Curative (C) | 2016-12-06 | 2016-12-07 | HD EuroNet-PHL-C1 OEPA | N | null | 270015108 | OEPA |
| 270019554 | 270009143 | 1.74 | 67.6 | null | 2019-03-25 | 2019-03-28 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | N | 270015115 | CETUXIMAB + IRINOTECAN + MDG |
| 270019555 | 270014280 | 1.98 | 109.3 | Not known (9) | 2017-01-23 | 2017-03-19 | Rituximab | 02 | N | 270015126 | RITUXIMAB |
| 270019556 | 270009151 | 1.83 | 86 | Curative (C) | null | 2018-07-14 | OEPA | N | N | 270015131 | OEPA |
| 270019557 | 270009160 | 1.76 | 52.2 | Curative (C) | 2019-06-15 | 2019-06-16 | ESHAP | N | N | 270015146 | ESHAP |
| 270019558 | 270009162 | 1.65 | 55.9 | Adjuvant (A) | 2018-08-29 | 2018-08-29 | Rituximab | N | N | 270015192 | RITUXIMAB |
| 270019559 | 270009184 | 1.69 | 73 | Adjuvant (A) | 2018-02-22 | 2018-02-22 | Rituximab (Maintenance) | N | Y | 270015226 | RITUXIMAB |
| 270019560 | 270009193 | 1.83 | 51.4 | Curative (C) | 2016-02-10 | 2016-02-11 | BEAM | N | null | 270015246 | BEAM |
| 270019561 | 270009195 | 1.67 | 60 | Curative (C) | 2017-10-20 | 2018-05-29 | Rituximab | null | null | 270015247 | RITUXIMAB |
| 270019562 | 270009214 | 1.73 | 78 | Disease modification (D) | null | 2016-01-26 | Rituximab | N | N | 270015286 | RITUXIMAB |
| 270019563 | 270009219 | 1.79 | 85.8 | Curative (C) | 2015-12-20 | 2016-06-10 | Rituximab | N | Y | 270015293 | RITUXIMAB |
| 270019564 | 270019654 | 1.39 | 62.8 | Curative (C) | 2014-10-25 | 2014-11-01 | BEAM | N | N | 270015309 | BEAM |
| 270019565 | 270009229 | null | null | Curative (C) | 2017-01-28 | 2017-02-22 | ESHAP | null | null | 270015310 | ESHAP |
| 270019566 | 270009231 | 1.74 | 131.6 | Palliative (P) | 2018-05-20 | 2018-07-01 | Cetuximab + FLUOROURACIL + IRINOTECAN | N | Y | 270015319 | CETUXIMAB + IRINOTECAN + MDG |